GRCENasdaq CM

Grace Therapeutics, Inc.

2.20+0.92%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tier
Alert levelinsufficient_liquidity

Tier and alert level are a summary. Unlock GRCE to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+3.29%, upReturn · 1w
−4.35%, downReturn · 1m
−5.58%, downReturn · 3m
−32.31%, downReturn · 1y
−57.53%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 50.

RSI (14)49.99Neutral
MACD / signal-0.03 / -0.05, favorable readingAbove signal line
SMA 502.27, caution readingPrice below
SMA 2003.11, caution readingPrice below
EMA 202.18, favorable readingPrice above
ADX (14)15.69Rangebound
+DI / −DI14.50 / 20.49−DI leading
ATR (14)0.104.4% of price — typical daily swing
Stochastic %K78.26Mid-range
Bollinger bands (20)2.04 – 2.22Inside bands
ROC (10)3.77, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking GRCE reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock GRCE: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get GRCE + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock GRCE